Respiri Share Price and Company Fundamentals



Price
$0.076
Change
-0.001 (-1.299%)
52 week
0.061 - 0.25

Last traded: Last Friday at 1:36 AM

Respiri Limited, an e-health SaaS company, researches, develops, and commercializes medical devices in Australia and Israel. The company develops, produces, and sells mobile health applications. Its products include Wheezo, an asthma management tool to help user understand their asthma by providing information, such as triggers, symptoms, medication usage, and other events. The company was formerly known as iSonea Limited and changed its name to Respiri Limited in December 2015. Respiri Limited is based in Melbourne, Australia.

Key Metrics

PE ratio

-

PB ratio

7.60

Dividend yield

Beta

-0.46

Market cap

$54.94M

Enterprise value

$47.07M

Company profile

Primary activitiese-Health SaaS company supporting respiratory health management.
Industry / SectorMedical Devices / Healthcare
Websitehttp://respiri.co
Mailing address432 St Kilda Road Suite 1 Level 9 Melbourne VIC 3004 Australia
Phone / Fax61 1300 11 7377 / 61 3 9822 7735
Share registryCOMPUTERSHARE INVESTOR SERVICES PTY LIMITED

Dividends

Respiri does not pay dividends.

Company Executives

As of Sep 2021, following are the company executives and directors listed on Respiri.

NameTitleAgeTotal Pay
Mr. Nicholas SmedleyExec. Chairman203.64k
Mr. Marjan Mikel B.Sc., M.A.I.C.D.CEO, MD & Exec. Director450k
Mr. Peter HildebrandtChief Operationg Officer249.88k
Dr. Samaneh Sarraf ShiraziChief Research Officer183.37k
Mr. Theo AntonopoulosChief Commercial Officer276.74k
Mr. Philippe LudekensGen. Mang. of Commercial Operations259.87k
Ms. Jan P. BarkerVice-Pres of Bus. Devel.
Mr. Alastair BeardCompany Sec.
Prof. Noam GavrielyMedical & Scientific Advisor
Mr. Simon GodfreyMedical & Scientific Advisor

Profitability and management effectiveness

Profit margin

0.00%

Operating margin

-800.27%

Return on assets

-101.01%

Return on equity

-219.38%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Respiri is 54.94M and its enterprise value is 47.07M. The enterprise value to revenue ratio of RSH is 33.96.

Companies similar to Respiri (RSH)

Respiri (ASX:RSH) Frequently Asked Questions

1. What is Respiri's Stock Symbol?

Respiri trades on ASX under the ticker symbol "RSH".

2. What is Respiri's stock price today?

One share of RSH stock can currently be purchased for approximately $0.076.

3. How can I contact Respiri?

Respiri's mailing address is 432 St Kilda Road Suite 1 Level 9 Melbourne VIC 3004 Australia. The company can be reached via phone at 61 1300 11 7377.

4. What is Respiri's official website?

The official website of Respiri is http://respiri.co.

5. Which share registry manages Respiri's stock?

Respiri's stock is managed by COMPUTERSHARE INVESTOR SERVICES PTY LIMITED.